Recent Advances in Treatment of Primary Central Nervous System Lymphoma

Therapeutic options are limited in primary central nervous system lymphoma (PCNSL) with no uniform consensus on optimal management and few published, randomized trials. High-dose methotrexate in combination with other chemotherapeutic agents forms the mainstay of treatment. There hasn’t been much pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayak, Lakshmi, Batchelor, Tracy T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Neuro-oncology (GJ Lesser, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841579/
https://www.ncbi.nlm.nih.gov/pubmed/23934511
http://dx.doi.org/10.1007/s11864-013-0252-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841579/
https://www.ncbi.nlm.nih.gov/pubmed/23934511
http://dx.doi.org/10.1007/s11864-013-0252-6

Ejemplares similares